Skip to main content

ROYAL BANK OF CANADA

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1000275 TORONTO, A6

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$43,777,199
-$333,629 QoQ
Shares Held
332,300
+6.8% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 94.47276557327716.ToString("F0")% Shared 4.789046042732471.ToString("F0")% None 0.7381883839903702.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
332,300 $43,777,199

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $43,777,199 332,300
2025-12-31 $44,110,828 311,012
2025-09-30 $34,347,613 244,676
2025-06-30 $15,227,592 121,152
2025-03-31 $9,158,784 82,810
2024-12-31 $8,269,988 60,586
2024-09-30 $29,140,287 252,910
2024-06-30 $22,774,607 165,429
2024-03-31 $19,167,290 138,974
2023-12-31 $16,146,788 122,547
2023-09-30 $5,414,398 48,128
2023-06-30 $4,139,294 43,895
2023-03-31 $11,915,920 117,723
2022-12-31 $14,494,281 121,352
2022-09-30 $12,097,103 113,898
2022-06-30 $10,520,527 107,925
2022-03-31 $6,687,653 71,335
2021-12-31 $5,240,082 61,525
2021-09-30 $5,730,428 59,748
2021-06-30 $6,567,054 67,479
2021-03-31 $6,012,286 61,823
2020-12-31 $5,519,137 57,581
2020-09-30 $4,018,524 41,790
2020-06-30 $3,619,496 29,668
2020-03-31 $2,393,278 27,652